Showing results 5 to 5 of 5
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Efficacy and safety analysis of Chinese patients in monarchE: abemaciclib combined with adjuvant endocrine therapy for high-risk HR+, HER2− early breast cancer Proceeding/Conference:Journal of Clinical Oncology | 2021 |